Hyaluronidase and trastuzumab and Insulin Detemir (Vials)
Determining the interaction of Hyaluronidase and trastuzumab and Insulin Detemir (Vials) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Trastuzumab and Hyaluronidase
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronidase and trastuzumab-Insulin detemir Subcutaneous
- Hyaluronidase and trastuzumab-Insulin glargine
- Hyaluronidase and trastuzumab-Insulin Glargine (U-100) Cartridge Systems and Pens
- Hyaluronidase and trastuzumab-Insulin Glargine (U-100) Vials
- Hyaluronidase and trastuzumab-Insulin Glargine (U-300) Pens
- Hyaluronidase and trastuzumab-Insulin glargine and lixisenatide
- Insulin Detemir (Vials)-Hyaluronidase injection
- Insulin Detemir (Vials)-Hyaluronidase Injection (Human)
- Insulin Detemir (Vials)-Hyaluronidase Subcutaneous, Injection
- Insulin Detemir (Vials)-Hyate:C
- Insulin Detemir (Vials)-Hybrisil
- Insulin Detemir (Vials)-Hycamtin